Quick View

Eli Lilly Q4 profit falls as generics hurt sales

Eli Lilly and Co said on Tuesday that fourth-quarter earnings had fallen as competition from generic drugs drove revenue lower. The US drugmaker said it had earned $827 million, or 74 cents per share, compared with $858 million, or 77 cents per share, a year earlier. Excluding special items such as asset impairments, restructuring and other special charges, Lilly earned 85 cents per share. Analysts on average were expecting 78 cents per share.

Ford Q4 net beats Street, predicts flat profit in 2013

Ford Motor posted better-than-expected fourth-quarter profit and predicted 2013 operating profit will be about equal to its performance last year, as market share gains in the US auto market offset deepening losses in Europe. The second largest US automaker expects to lose $2 billion in Europe, reflecting its deteriorating outlook for the region. Previously, Ford said it expected its 2013 loss in the region to close to last year's levels. But CFO Bob Shanks predicted Ford's losses in Europe will bottom out this year.

Pfizer Q4 nos top forecast, gives cautious 2013 view

Pfizer on Tuesday reported better-than-expected fourth-quarter results, helped by rebounding sales in emerging markets, but the drugmaker forecast earnings for 2013 that was mostly below consensus analyst expectations. The largest US drugmaker said its earnings quadrupled to $6.32 billion, or 86 cents per share, in the quarter as it recorded gains from the $12-bn sale in November of its nutritional products business to Swiss food groups Nestle SA.

ALSO READ

Google moves to end EU antitrust probe without fine

EU weighs iPhone sale deals

Mila Kunis becomes face of luxury jewellery company Gemfields

Next iPhone to have thinner screen